Seattle Genetics Thrives With Clay Siegall at the Helm

Clay Siegall and others founded Seattle Genetics in 1998. He is the company’s president and CEO. In addition to this position, Clay is also the chairperson of the company’s board of directors. His position and direction of the company has helped it to secure private financing to the tune of $ 1.2 billion.

Seattle Genetics

Siegall’s company is in the business of research, medicine development, scientific creativity and care for patients. The able leadership and the company’s solid foundation have enabled it to take a leading position in developing ‘antibody drug conjugates’. In 2011, FDA gave the company its node to go ahead and develop ADCENTRIS: Seattle Genetics’ first product. The Seattle Genetics brand has been accepted in over 60 countries, a testament of the solid partnership with ‘Takeda Pharmaceuticals’.

Prior Experience

In the past, Siegall worked for ‘Bristol-Myers Pharmaceutical Research Institute’. He started working here in 1997. He worked, three years, for ‘National Institute of Health’. Siegall is on ‘Alder BioPharmaceuticals’ and ‘Ultragenyx Pharmaceuticals’ board.

Awards

Clay Siegall’s work has not gone unnoticed. He is the recipient of many rewards. His old university awarded him in 2013 with the ‘University of Maryland Alumnus of the Year’ prize. This was an award for natural science. This award came a year after he had been awarded ‘Ernest & Young Entrepreneur of the Year’ award. He has published 70 papers and holds 15 patents.

Education

Clay Siegall studied Zoology at ‘University of Maryland’. His passion for understanding the DNA composition and matters of heredity drew him back to the university where he graduated with a Ph.D in Genetics from ‘George Washington University’.

Seattle Genetics’ Driving Force

Seattle Genetics is about finding a cure for cancer. As a teenager, Clay watched his father suffer from the torturous pangs of cancer. He suffered for five years before succumbing to the disease. Clay determined to study hard and research on cancer treatment.

New Entrepreneurs

To new entrepreneurs, wet behind the ears, Clay encourages them to interact more with the seasoned industry leaders. This interaction according to Clay will help the new entrepreneurs learn more about the market.

Leave a Reply

Your email address will not be published. Required fields are marked *